Egle Therapeutics inks $46.4m Series A

Egle Therapeutics SAS, an emerging biotechnology company, has raised $46.4 million in Series A financing.

Egle Therapeutics SAS, an emerging biotechnology company, has raised $46.4 million in Series A financing. LSP and Bpifrance led the round.

Source: Press Release